{"transactions":[{"id":848612,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-11T21:36:09.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029."}],"balance_after":5621,"derivative":{"exercise_price":0,"exercise_date":"2027-03-01","expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001919832-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000191983226000001/primary_doc.xml","form_type":"4"}},{"id":848611,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:36:09.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":769,"price":86.2224,"value":66305.0256,"ownership":{"direct":false,"nature":"See note (3)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Michael Chang PLLC (\"CHANG\") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares."}],"balance_after":82356,"source":{"system":"sec-edgar","filing":"0001919832-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000191983226000001/primary_doc.xml","form_type":"4"}},{"id":848610,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-11T21:36:09.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note (3)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Michael Chang PLLC (\"CHANG\") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares."}],"balance_after":83125,"source":{"system":"sec-edgar","filing":"0001919832-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000191983226000001/primary_doc.xml","form_type":"4"}},{"id":1172513,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-14T19:35:52.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 10, 2025, the Reporting Person was granted 2,500 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028."}],"balance_after":5000,"derivative":{"exercise_price":0,"exercise_date":"2026-03-01","expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001486189-25-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618925000013/primary_doc.xml","form_type":"4"}},{"id":1172512,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-14T19:35:52.000Z","date":"2025-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":266,"price":72.0972,"value":19177.8552,"ownership":{"direct":false,"nature":"See note (3)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Of the 1,250 shares issued subsequent to vesting, 266 shares were sold to cover tax withholding obligations."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Michael Chang PLLC  (\"CHANG\") is the direct beneficial owner of 80,057 shares of Common Stock.  Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares."}],"balance_after":81041,"source":{"system":"sec-edgar","filing":"0001486189-25-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618925000013/primary_doc.xml","form_type":"4"}},{"id":1172511,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-14T19:35:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See note (3)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Michael Chang PLLC  (\"CHANG\") is the direct beneficial owner of 80,057 shares of Common Stock.  Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares."}],"balance_after":81307,"source":{"system":"sec-edgar","filing":"0001486189-25-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618925000013/primary_doc.xml","form_type":"4"}},{"id":1467168,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-06-28T15:59:26.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Chang, dated June 28, 2024, the 37,500 RSUs granted to Dr. Change will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting"}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001486189-24-000034","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618924000034/primary_doc.xml","form_type":"4"}},{"id":2304285,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":61500,"kind":"person","name":"Chang Michael L.","position":1,"cik":"0001919832","reported_name":"Chang Michael L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-05T19:46:29.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":12008523,"ownership":{"direct":false,"nature":"By Michael Chang PLLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the closing of the business combination pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received  3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC."}],"balance_after":12008523,"source":{"system":"sec-edgar","filing":"0001062993-22-009699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000106299322009699/form4.xml","form_type":"4"}}]}